FK-506 and cyclosporin A : immunosuppressive mechanism of action and beyond
- 1 January 1992
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 4 (5) , 548-552
- https://doi.org/10.1016/0952-7915(92)90024-9
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.The Journal of Experimental Medicine, 1992
- FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurinNature, 1992
- Cyclosporin A, FK-506, and Rapamycin: Pharmacologic Probes of Lymphocyte Signal TransductionAnnual Review of Immunology, 1992
- A rapamycin-selective 25-kDa immunophilinBiochemistry, 1992
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: One in the presence and one in the absence of CsACell, 1991
- FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytesCellular Immunology, 1991
- Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?The Journal of Experimental Medicine, 1991
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- THE STRUCTURE AND REGULATION OF PROTEIN PHOSPHATASESAnnual Review of Biochemistry, 1989